Pharmakon Pharmaceuticals, Inc. FDA Inspection Record

FEI 3008213711 · Inspections, Form 483s, warning letters and import refusals

Pharmakon Pharmaceuticals, Inc. is an FDA-inspected facility (FEI 3008213711) located in Noblesville, IN, US. RegDataLab tracks 3 FDA inspections and 1 compliance action at this facility.

What FDA found at this site

Latest inspection
Mar 16, 2016: Official Action Indicated (OAI)
Inspections on record
3 (3 OAI)
Last OAI inspection
Mar 16, 2016
Warning letters
1 listed by FDA for this FEI, latest May 21, 2015
Form 483 and inspection documents
4 in FDA's reading room
Recalls as the recalling firm
5, latest Apr 20, 2016

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Mar 16, 2016Official Action Indicated (OAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Clothing appropriate for duties performed (21 CFR 211.28(a))
Penicillin processing area not kept separate (21 CFR 211.42(d))
Air Supply (21 CFR 211.42(c)(10)(iii))
and 8 more
Apr 8, 2014Official Action Indicated (OAI)SOPs not followed / documented (21 CFR 211.100(b))
Examination of packaging and labeling (21 CFR 211.130(d))
Examinations documented (21 CFR 211.134(c))
Signature and checking of records -- 2 persons (21 CFR 211.186(a))
and 2 more
Mar 13, 2014Official Action Indicated (OAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Apr 20, 2016Class IID-1256-2016Phenylephrine 40 mcg/mL injection in 0.9% Sodium Chloride 10 mL syringe, Rx Only… and 88 more products
Lack of Assurance of Sterility
Feb 11, 2016Class ID-0871-2016Morphine Sulfate 0.5 mg/mL, Preservative Free in 0.9% Sodium Chloride, Rx, total volume 1…
Super-Potent Drug: Out of specification for potency results (high) were obtained for one lot of morphine sulfate Inj.
Aug 19, 2015Class IID-0588-2016Ephedrine Sulfate 5 mg/mL in 0.9% Sodium Chloride, injectable packed in syringes, Total… and 21 more products
Stability data does not support expiry.
Apr 21, 2014Class ID-1565-2014Midazolam HCl 2 mg/ml in 0.9% Sodium Chloride in 30 mL PVC Vial, Rx Only. Pharmakon… and 3 more products
Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.
Mar 26, 2014Class ID-1362-2014Midazolam 0.2 mg/2 mL 0.9% Sodium Chloride syringes, Total dosage: 0.4 mg per 2 mL, Rx…
Superpotent Drug: Product contains twice the stated amount of midazolam.

Form 483s and inspection documents

  • 483 on FDA.gov
    FDA listing date Apr 15, 2016, which is not always the inspection or issue date. Published by FDA Jan 18, 2024.
  • 483 on FDA.gov
    Inspection Feb 18, 2016 to Mar 16, 2016, issued Mar 21, 2016 (dates printed on the document). FDA listing date Apr 15, 2016. Published by FDA Jan 18, 2024.
  • 483 on FDA.gov
    Inspection Feb 18, 2016 to Mar 16, 2016, issued Mar 16, 2016 (dates printed on the document). FDA listing date Apr 8, 2016. Published by FDA Jan 18, 2024.
  • 483 on FDA.gov
    Inspection Mar 5, 2014 to Mar 13, 2014, issued Mar 13, 2014 (dates printed on the document). FDA listing date Apr 15, 2016. Published by FDA Jan 18, 2024.

FDA record score

0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 22, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

9 records behind this number
RecordDatePoints x age weightAdds
Class II recall D-1256-2016, this FEI as the recalling firmApr 20, 201610 years or older, so it adds no points0
Inspection classified OAIMar 16, 201610 years or older, so it adds no points0
Class I recall D-0871-2016, this FEI as the recalling firmFeb 11, 201610 years or older, so it adds no points0
Class II recall D-0588-2016, this FEI as the recalling firmAug 19, 201510 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsMay 21, 201510 years or older, so it adds no points0
Class I recall D-1565-2014, this FEI as the recalling firmApr 21, 201410 years or older, so it adds no points0
Inspection classified OAIApr 8, 201410 years or older, so it adds no points0
Class I recall D-1362-2014, this FEI as the recalling firmMar 26, 201410 years or older, so it adds no points0
Inspection classified OAIMar 13, 201410 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 22, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 22, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 22, 2026Newest record Nov 13, 2026Current
Warning letter textNov 22, 2026Newest record Nov 17, 2026Current
Recalls (Enforcement Report)Nov 22, 2026Newest record Nov 18, 2026Current
Form 483s and inspection documentsNov 18, 2026Newest record Nov 17, 2026Current
Import refusalsNov 22, 2026Newest record Nov 12, 2026Current

Reviewing Pharmakon Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Pharmakon Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Pharmakon Pharmaceuticals, Inc.
Location
Noblesville, IN (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.